This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Herceptin
  • /
  • A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Her...
Clinical trial

A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin� [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)

Read time: 3 mins
Last updated:24th Feb 2014
Identifier: NCT01989676
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest